Guidance and Resources – Cervical Screening and STI
Case Introduction – Cervical Screening and STI
Further Case Information – Cervical Screening and STI
Background Science – Cervical Screening and STI
Case Conclusion – Cervical Screening and STI
Formative Assessment – Cervical Screening and STI
CASE Women’s Health – Cervical Screening and STI
In module Women’s Health
This case examines Jill, a 35 year old woman who presents for her routine cervical screening test and complains of an abnormal vaginal discharge and post-coital vaginal bleeding.
Introduction to cervical cancer screening Guidelines:
•2012 guidelines
•2019 update
•2021 update
•Main update is (Aligning management based on HPV natural history effect on cervical cancer understanding)
•Clearly defined risk thresholds were developed to categorize patients into low risk and high-risk patients.
Guidelines are updated from test-based algorithms to Risk based algorithms.
Updated US consensus guideline 3 available Cervical screening strategies:
1- HPV testing.
2- Cotesting ( HPV testing plus cervical cytology)
3- Cervical cytology.
Factors that affect patient’s risk include:
•Personal Factors:
•Age
•Immunosuppression status
•Test Results:
•Current screening test results
•previous screening test results
•biopsy results
Patients Risks:
•Higher risk patients
•More frequent surveillance
•Colposcopy
•Treatment
•Lower risk patients
• Longer interval surveillance
•Routine screening
Cervical Screening and STI ILOs
CASE COMPONENT
Guidance and Resources – Cervical Screening and STI
In case Women’s Health – Cervical Screening and STI
eBooks:
1) Essentials by Hacker and moore
2) Platform algorithm
3) Johns Hopkins Handbook of Obstetrics & Gynecology. (6th edition)
· Follow the link above
· Under Institutional Access, select UK Access Management Federation in the drop down box options and click Go.
· Find The University of Manchester Library in the list of institutions and click on it.
· Enter your university username and password when prompted.
By the end of this case, you should be able to
· Formulate a differential diagnosis and management plan for vaginal discharge and postcoital bleeding
· Recognise the normal anatomy and physiology of the vagina, including normal flora and the common pathogens causing vaginal infections including bacterial vaginosis, trichomonas, candida, and common STIs
· Understand the NHS cervical screening program processes, including HPV triage and how to counsel women with an abnormal smear
· Revisit the Wilson and Junger criteria for screening and consider this in relation to the NHS screening process.
· Understand what happens at a colposcopy clinic and who and when patients should be referred
· Understand the natural history and histology of cervical intraepithelial neoplasia and how it is treated
· Revisit the pathophysiology of cervical cancer, risk factors, diagnosis and treatment, including FIGO staging
Resources
1-John Hopkins manual of GYN&OBS(6TH edition)
2-Hacker and Moore 6th edition ( 2016)
3-2019 updated guidelines references:
A- introduction to guidelines update
presentation: power point.
C- https://www.medscape.com/viewarticle/804592
3- 2021 updated cervical cancer guidelines
Speculum examination and swab taking:
V1
Sexually Transmitted Infections in Primary Care – Royal College of General Practitioners
Management of Vaginal Discharge in Non-Genitourinary Medicine Settings – RCOG
Clinical features of genital infections
NHS Cervical Screening Programme
Colposcopy and Cervical Treatments.
What happens during colposcopy?
Case Introduction – Cervical Screening and STI
In case Women’s Health – Cervical Screening and STI
Mrs Jill Barnes, a 35 year old office worker has been referred to you by the practice nurse after she presented for her cervical screening and mentioned some vaginal discharge.
From her medical history you note:
· Nulliparous
· Previous history of chlamydia infection treated 15 years ago
· Previous cervical smear normal
· No medical conditions
· Medications;
· Microgynon 30
· No known drug allergies
What questions would you want to ask about the discharge?
· Colour
· Consistency
· Blood
· Duration
· Timing? Cyclical/constant
· Odour
· Previous history
· Sexual and menstrual history
In questioning – you are trying to elucidate what may be the cause of the discharge. Is the patient at higher risk of a sexually transmitted infection – her sexual history if important. Does the patient have an infection? If so, offensive odour may be indicative. Bleeding will raise concern of a non-infective and possible malignant cause of discharge.
What is your differential diagnosis?
Infective (non-sexually transmitted)
· Bacterial vaginosis
· Candida
Infective (sexually transmitted)
· Chlamydia trachomatis
· Neisseria gonorrhoeae
· Trichomonas vaginalis
· Herpes simplex virus
Non-infective
· Foreign bodies (e.g. retained tampons, condoms)
· Cervical polyps and ectopy
· Genital tract malignancy
· Fistulae
On further questioning Jill tells you she has had some post coital bleeding.
What questions would you now like to ask?
· Timing? Duration? Previous history?
· Dyspareunia
· IMB
· Menstrual history
· Smear history
· Any other symptoms?
Again, you are trying to establish a diagnosis from the patient’s history. It is important to check that she has a normal smear history as post-coital bleeding can be a sign of cervical malignancy. It is also important to note however, that a woman can present with cervical cancer even if her smears have been normal.
Jill tells you her periods are regular and she has no other symptoms besides the vaginal discharge already mentioned and explored. She has a history of a chlamydia infection when she was younger but no other STIs and she has never been pregnant.
After you have taken a detailed history you consent Jill to having a vaginal/speculum examination and swab tests with a chaperone.
Speculum examination and swab taking:
Your examination findings are as follows:
· Normal external genitalia.
· Normal appearance of vagina. Cervix appears normal with a small ectropion
· A small amount of thin, grey discharge was present.
· Bimanual examination revealed a normal sized, anteverted uterus with no adnexal masses or cervical excitation.
What does this image show?
· CIN 1
· Ectropion
· Cervicitis
· Normal cervix
· Cervical cancer
· Normal cervix
.Should have been checked.
What does this image show?
· Ectropion
· Normal cervix
· CIN 1
· Cervical cancer
. Cervicitis
· Ectropion
.Correct answer.
Note the reddened area around the external os
Further Case Information – Cervical Screening and STI
COLPOSCOPY
She is seen in Colposcopy clinic within 2 weeks. The gynaecologist performs a colposcopic examination and decides Jill needs a Large Loop excision of the Transformation zone (LLETZ), which she does as a ‘see and treat’ procedure in clinic under local anaesthetic. She tells Jill she will write to her with the results.
This image shows an example of what a cervix may look like after staining with acetic acid, as happens during a colposcopy – (It does not show what was seen at Jill’s colposcopy).
What does this image show?
· Normal cervix
· CIN 1
· Cervicitis
· Ectropion
· Cervical cancer
· CIN 1
Note the pale patches around the external os. During colposcopy, when staining with acetic acid, areas of CIN are seen as white.
Should have been checked.
Large Loop excision of the Transformation zone (LLETZ)
Removal of the transformation zone with a loop diathermy device, usually under local anaesthetic (cervical block). This method has a 90-95% cure rate
Histology report
Clinical Information:
Moderate (high grade) dyskaryosis with HPV, high grade appearance at colposcopy
MACRO
A loop biopsy of the cervix measuring 19 x 15mm and up to 10mm deep. Cervical os is obscured by mucus. The loop was divided into 5 sections and processed in its entirety
MICRO
Sections show the squamo-columnar junction has been sampled. The squamous epithelium shows CIN 2 with HPV changes. No evidence of invasive malignancy. The atypical epithelium appears completely excised.
Diagnosis
CIN 2 with HPV changes, completely excised
Given this result, when should Jill be followed up?
· Back to routine recall
· 6 month smear
· 12 month smear
· 6 months in colposcopy for repeat biopsy
· 12 months in colposcopy for repeat biopsy
· 6 month smear
.Correct answer.
If this test is normal, when should her next smear be?
· 6 months
· 12 months
· 18 months
· 2 years
· 3 years
· 3 years
Large Loop excision of the Transformation zone (LLETZ)
Removal of the transformation zone with a loop diathermy device, usually under local anaesthetic (cervical block). This method has a 90-95% cure rate
Histology report
Clinical Information:
Moderate (high grade) dyskaryosis with HPV, high grade appearance at colposcopy
MACRO
A loop biopsy of the cervix measuring 19 x 15mm and up to 10mm deep. Cervical os is obscured by mucus. The loop was divided into 5 sections and processed in its entirety
MICRO
Sections show the squamo-columnar junction has been sampled. The squamous epithelium shows CIN 2 with HPV changes. No evidence of invasive malignancy. The atypical epithelium appears completely excised.
Diagnosis
CIN 2 with HPV changes, completely excised
Background Science – Cervical Screening and STI
Changes in Terminology:
CIN 1 is referred to as LSIL. CIN 2 that is negative for p16, a marker for high-risk HPV, is referred to as LSIL. Those that are p16-positive are referred to as HSIL. CIN 3 is referred to as HSIL.
Dyskaryosis is not a histological diagnosis; it is merely a description of how abnormal the cells on the surface of the cervix appear. It often corresponds with CIN i.e. mild dyskaryosis – CIN 1, moderate CIN 2 etc, but a smear cannot diagnose CIN. A biopsy must be taken to assess the depth of invasion and therefore the grade of CIN.
Low-grade dyskaryosis; this is indicated by the presence of dyskaryotic cells with a nuclear: cytoplasmic diameter ratio of <50%. Such cells may also show koilocytosis, indicated by the presence of a large, sharply defined, clear perinuclear halo, surrounded by a condensed rim of cyanophilic or eosinophilic cytoplasm.
High-grade dyskaryosis (moderate); Dyskaryotic cells are present with a nuclear: cytoplasmic diameter ratio of >50%, but <75% Distinguishing precisely between high-grade dyskaryosis (moderate) and high-grade dyskaryosis (severe) is difficult.
High-grade dyskaryosis (severe); this should be used when dyskaryotic cells are present with a nuclear: cytoplasmic diameter ratio of no less than 50%, and probably >75%
Around 1:20 women will have some form of abnormal smear result.
IT IS NOT CANCER.
Abnormal cells often return to normal cells on their own, but if left untreated, these changes may develop into cancer in the future.
HPV testing
In 2011, HPV triage and test of cure was introduced in England, Wales and Northern Ireland. This was introduced to try to reduce burden on colposcopy units and avoid unnecessary biopsies and treatments. It also means women with significant abnormalities (i.e. those associated with high risk HPV) are referred sooner for colposcopy, and those without high risk HPV can be quickly returned to routine recall. This will reduce anxiety for many patients.
HPV triage means that all smears that are reported as borderline or mild dyskaryosis are now tested for HPV. Those that are positive will be referred to colposcopy, and negative will be returned to routine recall.
HPV test of cure means that all women who have been treated for CIN (usually with a Loop excision – discussed later in the case) will have a test for HPV 6 months following their treatment. If this is negative, they need no further follow up and can return to routine recall. If this test is positive they will need further follow up with colposcopy.
HPV is the virus associated with genital warts, there are more than 100 different types, but some types are more associated with genital warts, and some with cervical cancer – the ones more associated with cervical cancer are termed ‘high risk HPV’. Again this does not mean that she will definitely get cancer. HPV is sexually transmitted but it can lay dormant without symptoms for many years. It is estimated that over 75% of sexually active women has been infected with one or more type of HPV.
Normal cervix
LSIL- Abnormal cells confined to lower 1/3 of squamous epithelium
HGSIL=CIN 2 – Abnormal cells confined to lower 2/3 of squamous epithelium
HGSIL=CIN 3 – Abnormal cells affect full thickness of squamous epithelium
Normal cervix
CIN 1- Abnormal cells confined to lower 1/3 of squamous epithelium
CIN 2 – Abnormal cells confined to lower 2/3 of squamous epithelium
CIN 3 – Abnormal cells affect full thickness of squamous epithelium
CIN Grade % regression % persist % progress to CIS % progress to invasive cancer
1 57% 32% 11% 1%
2 43% 35% 22% 5%
3 32% 56% <12%
Not all CIN will progress through the stages, majority of low-grade disease spontaneously resolves – thought to be related to body developing immunity to HPV and clearing the virus.
CASE COMPONENT
Case Conclusion – Cervical Screening and STI
In case Women’s Health – Cervical Screening and STI
Jill’s GP receives her swab results.
HVS result as follows:
· pH 4.7 (normal 3.8 – 4.2)
· No candida species isolated
· Overgrowth of Gardenerella vaginalis
· Clue cells present
· Culture negative
G. Vaginalis (gram stain)
Clue cells – Note the epithelial vaginal cell is covered with bacteria
What is the diagnosis?
Bacterial vaginosis
How would this be treated?
· Metronidazole
· Amoxicillin
· Co-Amoxiclav
· Clotrimazole
· Erythromycin
· Metronidazole
.Correct answer.
Formative Assessment – Cervical Screening and STI
What lab test do we perform on a High Vaginal Swab?
· Microscopy
· Culture
· Microscopy, sensitivity and culture
· Chlamydia and gonorrhoea testing
· All of the above
Microscopy, sensitivity and culture
.Correct answer.
What will the lab technician look for when analysing the swab under the microscope? (Tick all that apply)
· Pubic lice
· Trichomonas vaginalis
· White cell count
· Epithelial cells
· Bacterial vaginosis
· Epithelial cells
· Bacterial vaginosis
What proportion of CIN 1 will progress to invasive cervical cancer?
· 1%
· 5%
· 12%
· 20%
· 50%
· 1%
What proportion of CIN 2 will progress to invasive cervical cancer?
· 1%
· 5%
· 12%
· 20%
· 50%
· 5%
What proportion of CIN 3 will progress to invasive cervical cancer?
· 1%
· 5%
· 12%
· 20%
· 50%
12%
Which of the following are symptoms of cervical cancer?
· Post-coital bleeding
· Vaginal discharge
· Intermenstrual bleeding
.· Abdominal pain
· All of the above
All of the above
.Should have been checked.
A woman presents with cream, cottage cheese-like discharge and vulval itching.
What is the most likely diagnosis?
· Bacterial vaginosis
· Candida
· Pubic lice
· Chlamydia
· Trichomonas
· Candida
.Correct answer.
What is the age group routinely invited for cervical screening in the UK?
· 20-60
· 20-65
· 25-60
· 25-65
· 25-70
25-65
.Should have been checked.
How do we define CIN 2 on histology?
· Abnormal cells covering full thickness of epithelium
· Abnormal cells covering 1/3 thickness of epithelium
· Abnormal cells covering 2/3 thickness of epithelium
· Abnormal cells covering ½ thickness of epithelium
· Abnormal cells invading through basement membrane
· Abnormal cells covering 2/3 thickness of epithelium
.Correct answer.